Director Mark Kahrer buys 20,000 DNP (NYSE: DNP) shares
Rhea-AI Filing Summary
DNP Select Income Fund director Mark G. Kahrer bought 20,000 shares of common stock in an open-market transaction at $10.21 per share on February 11, 2026. Following this purchase, he directly owns 23,000 DNP shares. The transaction was reported as a routine Form 4 insider purchase.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 20,000 shares
Net Buy
1 txn
Insider
Kahrer Mark G.
Role
Director
Bought
20,000 shs ($204K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common stock | 20,000 | $10.21 | $204K |
Holdings After Transaction:
Common stock — 23,000 shares (Direct)
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did DNP (DNP) report for director Mark G. Kahrer?
DNP reported that director Mark G. Kahrer bought 20,000 common shares in an open-market transaction. He paid $10.21 per share and now directly owns 23,000 DNP shares, according to the Form 4 insider trading report.
Was the recent DNP (DNP) insider trade a purchase or a sale?
The recent DNP insider trade by director Mark G. Kahrer was a purchase. He acquired 20,000 common shares in an open-market transaction at $10.21 per share, increasing his direct holdings to 23,000 shares of DNP stock.
What does the Form 4 filing reveal about DNP (DNP) insider ownership changes?
The Form 4 filing shows an increase in insider ownership by director Mark G. Kahrer. He purchased 20,000 DNP common shares at $10.21 each, bringing his direct holdings to 23,000 shares following the reported open-market transaction.